Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papilloma Virus Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Not applicableStudy completedNCT06702423
What this trial is testing

AI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan

Who this might be right for
Healthy
The University of Hong Kong 804
Not applicableTemporarily pausedNCT05677360
What this trial is testing

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS)

Who this might be right for
Human Papilloma Virus (HPV) Vaccine
H. Lee Moffitt Cancer Center and Research Institute 564
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07628062
What this trial is testing

Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation

Who this might be right for
HPV-Positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaHead and Neck Cancer
ImmunityBio, Inc. 70
Not applicableNot Yet RecruitingNCT06743880
What this trial is testing

Knowledge, Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population

Who this might be right for
Human Papilloma Virus (HPV) Vaccine
Assiut University 323
Not applicableStudy completedNCT01769560
What this trial is testing

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

Who this might be right for
Human Papillomavirus-Related Carcinoma
University of Michigan 661
Not applicableStudy completedNCT03399396
What this trial is testing

Increasing HPV Vaccination in Community-Based Pediatric Practices

Who this might be right for
HPV Vaccines
Pamela Hull 420
Not applicableWithdrawnNCT00863096
What this trial is testing

Human Papillomavirus Screening and Vaccine Readiness Program

Who this might be right for
Human Papilloma Virus-Related Carcinoma
Public Health Research Institute, India 450
Post-approval studies (Phase 4)Study completedNCT01386164
What this trial is testing

Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults

Who this might be right for
HIVHuman Papillomavirus
University of Aarhus 92
Not applicableUnknownNCT03604393
What this trial is testing

Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise

Who this might be right for
Human Papilloma Virus
Oregon Health and Science University 22,000
Not applicableStudy completedNCT00730704
What this trial is testing

Acceptance of Human Papillomavirus Vaccination in Postpartum Women

Who this might be right for
Human Papilloma VirusHPVPost Partum
Columbia University 150
Post-approval studies (Phase 4)Looking for participantsNCT05495906
What this trial is testing

Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

Who this might be right for
HPVHuman Papilloma VirusHuman Immunodeficiency Virus
University of British Columbia 275
Post-approval studies (Phase 4)Study completedNCT01914367
What this trial is testing

Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)

Who this might be right for
Infection With Human Papillomavirus
University Hospital, Ghent 12
Post-approval studies (Phase 4)Study completedNCT02236234
What this trial is testing

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil

Who this might be right for
Infection
University of Sao Paulo 30
Not applicableStudy completedNCT04023955
What this trial is testing

Promoting HPV Vaccine Through Twitter

Who this might be right for
Human Papilloma Virus
Tufts University 48
Post-approval studies (Phase 4)Ended earlyNCT00730847
What this trial is testing

Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards.

Who this might be right for
Human Papillomavirus Infection Leading to Cervical Cancer
GlaxoSmithKline 743
Large-scale testing (Phase 3)Study completedNCT01254643
What this trial is testing

The Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008).

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)Study completedNCT00002916
What this trial is testing

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Who this might be right for
Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Early research (Phase 1)Study completedNCT00478621
What this trial is testing

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 540
Next Page